Home › Funds › GUARDIAN INVESTMENT MANAGEMENT › GILD

GUARDIAN INVESTMENT MANAGEMENT position in GILD

GILEAD SCIENCES INC · Health Care

GUARDIAN INVESTMENT MANAGEMENT reported holding 3,750 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$559K, representing 0.36% of its reported portfolio and ranking #43 among its reported holdings. GUARDIAN INVESTMENT MANAGEMENT has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.75K sh
Reported value held$558.94K
Portfolio Weight0.36%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GUARDIAN INVESTMENT MANAGEMENT's GILD position evolved

GUARDIAN INVESTMENT MANAGEMENT first disclosed a stake in GILD in Q3 2023 at 7,550 shares (US$547K). The position peaked in Q3 2026 at 3,750 shares, worth US$559K. Across 13 filings, GUARDIAN INVESTMENT MANAGEMENT increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 3,750 shares valued at US$559K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.55K $547.06K New
Q4 2023 5.90K $477.96K Reduce
Q1 2024 5.90K $432.18K Hold
Q2 2024 5.65K $432.18K Reduce
Q3 2024 5.65K $473.70K Hold
Q4 2024 4.75K $438.76K Reduce
Q1 2025 3.75K $420.19K Reduce
Q2 2025 3.75K $415.76K Hold
Q3 2025 3.75K $416.25K Hold
Q4 2025 3.75K $460.27K Hold
Q1 2026 3.75K $522.64K Hold
Q2 2026 3.75K $473.77K Hold
Q3 2026 3.75K $558.94K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has GUARDIAN INVESTMENT MANAGEMENT held GILD?

GUARDIAN INVESTMENT MANAGEMENT has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GUARDIAN INVESTMENT MANAGEMENT's current position in GILD?

As of Q3 2026, GUARDIAN INVESTMENT MANAGEMENT holds 3.75K shares of GILD (GILEAD SCIENCES INC), valued at $558.94K, representing 0.36% of its reported portfolio and ranking #43.

Has GUARDIAN INVESTMENT MANAGEMENT been buying or selling GILD?

In the latest 13F filing (Q3 2026), GUARDIAN INVESTMENT MANAGEMENT held unchanged its position in GILD. The position peaked in Q3 2026 at 3.75K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.